Xrf Scientific Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xrf Scientific Ltd with three other
companies in this sector in Australia:
sales of 18.61 million Australian Dollars [US$14.65 million]
of which 88%
was Drug discovery and development),
Clinuvel Pharmaceuticals Limited
(17.03 million Australian Dollars [US$13.41 million]
of which 100%
was Biotechnology), and
(17.64 million Australian Dollars [US$13.89 million]
of which 77%
was Bronchitol and Aridol).
Xrf Scientific Ltd reported sales of A$21.54 million (US$16.96 million)
June of 2017.
a very small
increase of 1.9%
versus 2016, when the company's sales were A$21.13 million.
Sales of Consumables saw an increase
that was more than double the company's growth rate: sales were up
10.0% in 2017, from
A$6.27 million to A$6.90 million.
Xrf Scientific Ltd also saw significant increases in sales in
Capital Equipment (up 5.1% to A$6.02 million)
Not all segments of Xrf Scientific Ltd experienced an increase in sales in 2017:
sales of Eliminations/unallocated fell 61.1% to A$32,209.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).
Xrf Scientific Ltd also experienced decreases in sales in
Precious Metals (down 5.1% to A$8.59 million)